22:21 , Aug 22, 2019 |  BC Extra  |  Financial News

Microbiome company Finch raises $53M ahead of anti-infective readout

Finch's series C round is designed to carry the microbiome company through what could be a pivotal data readout next year in Clostridium difficile infection, while also allowing it to continue building on a pair...
17:33 , Mar 2, 2018 |  BC Week In Review  |  Financial News

Finch Therapeutics raises $36 million series B round

Finch Therapeutics Group Inc. (Somerville, Mass.) raised $36 million on March 1 in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital. The original target was $30 million....
16:24 , Mar 1, 2018 |  BC Extra  |  Financial News

Finch Therapeutics raises $36M series B round

Finch Therapeutics Group Inc. (Somerville, Mass.) raised $36 million in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital. The original target was $30 million. CEO Mark Smith...